1. Academic Validation
  2. Atonal homolog 7 (ATOH7) loss-of-function mutations in predominant bilateral optic nerve hypoplasia

Atonal homolog 7 (ATOH7) loss-of-function mutations in predominant bilateral optic nerve hypoplasia

  • Hum Mol Genet. 2020 Jan 1;29(1):132-148. doi: 10.1093/hmg/ddz268.
David Atac 1 Samuel Koller 1 James V M Hanson 2 Silke Feil 1 Amit Tiwari 1 Angela Bahr 1 Luzy Baehr 1 István Magyar 1 Raimund Kottke 3 Christina Gerth-Kahlert 2 Wolfgang Berger 1 4 5
Affiliations

Affiliations

  • 1 Institute of Medical Molecular Genetics, University of Zurich, Schlieren 8952, Switzerland.
  • 2 Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland.
  • 3 Department of Diagnostic Imaging, University Children's Hospital Zurich, Zurich 8032, Switzerland.
  • 4 Zurich Center for Integrative Human Physiology, University of Zurich, Zurich 8057, Switzerland.
  • 5 Neuroscience Center Zurich, University and ETH Zurich, Zurich 8057, Switzerland.
Abstract

Optic nerve hypoplasia (ONH) is a congenital optic nerve abnormality caused by underdevelopment of retinal ganglion cells (RGCs). Despite being a rare disease, ONH is the most common optic disk anomaly in ophthalmological practice. So far, mutations in several genes have been identified as causative; however, many cases of ONH remain without a molecular explanation. The early transcription factor atonal basic-helix-loop-helix (bHLH) transcription factor 7 (ATOH7) is expressed in retinal progenitor cells and has a crucial role in RGC development. Previous studies have identified several mutations in the ATOH7 locus in cases of eye developmental diseases such as non-syndromic congenital retinal non-attachment and persistent hyperplasia of the primary vitreous. Here we present two siblings with a phenotype predominated by bilateral ONH, with additional features of foveal hypoplasia and distinct vascular abnormalities, where whole-exome Sequencing identified two compound heterozygous missense mutations affecting a conserved amino acid residue within the bHLH domain of ATOH7 (NM_145178.3:c.175G>A; p.(Ala59Thr) and c.176C>T; p.(Ala59Val)). ATOH7 expression constructs with patient single nucleotide variants were cloned for functional characterization. Protein analyses revealed decreased protein amounts and significantly enhanced degradation in the presence of E47, a putative bHLH dimerization partner. Protein interaction assays revealed decreased heterodimerization and DNA-binding of ATOH7 variants, resulting in total loss of transcriptional activation of luciferase reporter gene expression. These findings strongly support pathogenicity of the two ATOH7 mutations, one of which is novel. Additionally, this report highlights the possible impact of altered ATOH7 dimerization on protein stability and function.

Figures